WhiteLab Genomics
Unleashing the potential of DNA and RNA based therapies using AI
Winter 2022Healthcare / Healthcare -> Drug Discovery and DeliveryParis, Île-de-France, France; Boston, MA, USA40 employees
Artificial Intelligence
Gene Therapy
Cell Therapy
Genomics
About
We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.
Build your own investing agent
GPAgent keeps YC listings public and neutral. Fund-specific scoring, notes, and workflow state live in each customer workspace.
Join the GPAgent waitlistDetails
Status
Active
Stage
Growth
Team Size
40
Regions
France, United States of America, Europe, America / Canada, Remote, Partly Remote